Offers started delivery rivastigmine tartrate capsules.

Caraco Pharmaceutical Laboratories commences marketing of rivastigmine tartrate capsules Caraco Pharmaceutical Laboratories, Ltd. offers started delivery rivastigmine tartrate capsules. Rivastigmine tartrate is normally indicated for treatment of mild to moderate Alzheimer’s dementia and gentle to moderate Parkinson’s disease dementia.Related StoriesCollaborative approach may rate discovery of fresh preventive remedies for Alzheimer's diseaseEight myths and truths about Alzheimer's diseaseNew technique helps research protein changes in brain tissue of Alzheimer's patientsPhillip Frost, M.D., Chairman and Chief Executive Officer of OPKO, stated, We are pleased to use Bristol-Myers Squibb to generate extra validation data that may expedite the approval and marketing of our simple bloodstream check for Alzheimer’s disease and cognitive disorders that may precede it. As fresh and better forms of therapy for Alzheimer’s disease become obtainable, particularly the ones that can gradual its progression, early and definitive diagnosis will be of critical importance.